Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
50,891 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00222898 | Cancer Detection in Pancreatic Cysts | completed | — | 300 | University of PittsburghOTHER | 1 | Feb 19, 2007 | clinicaltrials |
| NCT00273884 | Amonafide in Combination With Cytarabine in Secondary AML | completed | Phase 2 | 80 | Xanthus Pharmaceuticals, Inc.INDUSTRY | 2 | Feb 19, 2007 | clinicaltrials |
| A Study to Assess Two Different Strategies of Combining Dexamethasone and VELCADE |
| no longer available |
| — |
| — |
| Millennium Pharmaceuticals, Inc.INDUSTRY |
| 1 |
| Feb 14, 2007 |
| clinicaltrials |
| NCT00415285 | Docetaxel Followed by Capecitabine Versus Concomitant Docetaxel/Capecitabine for Early Stage Breast Cancer | unknown | Phase 2 | 100 | Georgia Center for Oncology Research & EducationOTHER | 1 | Feb 13, 2007 | clinicaltrials |
| NCT00287482 | Essiac (ESIAK) Versus Placebo to Improve Quality of Life in Transition in Women With Breast or Ovarian Cancer. | terminated | N/A | 20 | Women and Infants Hospital of Rhode IslandOTHER | 1 | Feb 12, 2007 | clinicaltrials |
| NCT00055250 | A Study With LY293111, Gemcitabine and Placebo in Patients With Pancreatic Cancer | completed | Phase 2 | 130 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00061464 | Pemetrexed Plus Gemcitabine for Patients With Locally Advanced or Metastatic NSCLC Who Have Not Had Previous Chemotherapy. | completed | Phase 2 | 48 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00061477 | Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Malignant Pleural or Peritoneal Mesothelioma | completed | Phase 2 | 48 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00071136 | Pemetrexed and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 1 / Phase 2 | 48 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00190593 | Raloxifene Use for The Heart | completed | Phase 3 | 10,000 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00190723 | A Study of LY317615 in Patients With Brain Tumors | completed | Phase 2 | 120 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00191230 | Gemcitabine/Platinum Containing Regimens as Preoperative Chemotherapy for Patients With Non Small Cell Lung Cancer | completed | Phase 2 | 70 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00191256 | Efficacy Trial of Gemcitabine Containing Regimens As Preoperative Chemotherapy in Non Small Cell Lung Cancer | completed | Phase 2 | 77 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00191607 | A Randomized Trial for Patients With Platinum Resistant Ovarian, Fallopian or Primary Peritoneal Cancer. | completed | Phase 3 | 162 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00191672 | A Trial Of Gemcitabine Plus Paclitaxel And Gemcitabine Plus Docetaxel In Metastatic Breast Cancer | completed | Phase 2 | 120 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00191750 | A Study of Pemetrexed in Small Cell Lung Cancer, Which Has Returned | completed | Phase 2 | 80 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00200187 | A Randomized Study of the Efficacy of Low Venous Pressure General Anesthesia Versus Combined Spinal-Epidural Anesthesia in Decreasing Blood Loss During Prostate Surgery | completed | Phase 2 | 246 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00260026 | Safety and Pharmacokinetics of Jin Fu Kang in Comb w/Docetaxel for Patients w/Non-Small Cell Lung Cancer | completed | Phase 2 | 20 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00040586 | Phase II Trial of Monoclonal Antibody (J591) in Combination With Low-Dose Subcutaneous Interleukin-2 | completed | Phase 2 | — | BZL BiologicsINDUSTRY | 1 | Jan 22, 2007 | clinicaltrials |
| NCT00280930 | Letrozole in Postmenopausal Women at Increased Risk for Breast Cancer | unknown | Phase 2 | 60 | Dana-Farber Cancer InstituteOTHER | 1 | Jan 19, 2007 | clinicaltrials |
| NCT00230191 | Safety and Efficacy of RK0202 in Oral Mucositis | completed | Phase 2 | 110 | RxKinetixINDUSTRY | 2 | Jan 15, 2007 | clinicaltrials |
| NCT00232128 | Protocol for Radiofrequency Ablation of Pulmonary Neoplasms | terminated | N/A | — | Oncology Specialties, AlabamaOTHER | 1 | Jan 12, 2007 | clinicaltrials |
| NCT00123877 | Study of GPX-100 in the Treatment of Metastatic Breast Cancer | terminated | Phase 2 | 40 | Gem PharmaceuticalsINDUSTRY | 2 | Jan 9, 2007 | clinicaltrials |
| NCT00034034 | Acupuncture to Reduce Symptoms of Advanced Colorectal Cancer | completed | Phase 1 | 105 | National Center for Complementary and Integrative Health (NCCIH)NIH | 1 | Jan 5, 2007 | clinicaltrials |
| NCT00000433 | Blocking Tumor Necrosis Factor in Ankylosing Spondylitis | completed | Phase 2 | 42 | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)NIH | 1 | Jan 4, 2007 | clinicaltrials |
| NCT00074646 | Phase I Trial of CC-8490 for the Treatment of Subjects With Recurrent/Refractory High-Grade Gliomas | completed | Phase 1 | 36 | Celgene CorporationINDUSTRY | 1 | Jan 4, 2007 | clinicaltrials |
| NCT00179686 | A Study to Evaluate the Single-Agent Lenalidomide in Subjects With Recurrent Non-Small-Cell Lung Cancer | completed | Phase 2 | 40 | Celgene CorporationINDUSTRY | 1 | Dec 20, 2006 | clinicaltrials |
| NCT00072722 | Safety and Efficacy of CC-4047 in Subjects With Metastatic Hormone Refractory Prostate Cancer (HRPC) | completed | Phase 2 | 36 | Celgene CorporationINDUSTRY | 1 | Dec 19, 2006 | clinicaltrials |
| NCT00413179 | The Effect of Metformin Added to Clomiphene Citrate on Pregnancy Rates in Hyperandrogenic, Chronic Oligoovulatory or Anovulatory Women | completed | Phase 3 | 56 | 59th Medical WingFED | 1 | Dec 19, 2006 | clinicaltrials |
| NCT00088647 | Study Evaluating MST-997 in Advanced Malignant Solid Tumors | terminated | Phase 1 | — | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Dec 8, 2006 | clinicaltrials |
| NCT00277836 | Study Evaluating MST-997 in Advanced Malignant Solid Tumors | terminated | Phase 1 | 60 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Dec 8, 2006 | clinicaltrials |
| NCT00062907 | Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer | unknown | Phase 1 | 9 | Corixa CorporationINDUSTRY | 1 | Dec 6, 2006 | clinicaltrials |
| NCT00186511 | Expanding Rural Access: Distance Delivery of Support | completed | Phase 2 | 40 | Stanford UniversityOTHER | 1 | Dec 5, 2006 | clinicaltrials |
| NCT00214838 | An Open-Label Study of the Safety and Efficacy of Atiprimod Treatment for Patients With Advanced Cancer | unknown | Phase 1 / Phase 2 | 61 | Callisto PharmaceuticalsINDUSTRY | 1 | Dec 5, 2006 | clinicaltrials |
| NCT00058656 | Autologous T Cell Immunotherapy for Chronic Lymphocytic Leukemia (CLL) Patients | completed | Phase 1 / Phase 2 | 18 | Xcyte TherapiesINDUSTRY | 1 | Nov 22, 2006 | clinicaltrials |
| NCT00037791 | Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia | completed | Phase 3 | 180 | PfizerINDUSTRY | 3 | Nov 9, 2006 | clinicaltrials |
| NCT00074854 | A Clinical Efficacy Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 Given In Combination With Chemotherapy | completed | Phase 1 / Phase 2 | 87 | PfizerINDUSTRY | 1 | Nov 9, 2006 | clinicaltrials |
| NCT00078468 | Study of the GARFT Inhibitor AG2037 in Patients With Metastatic Colorectal Cancer Who Failed Treatment | completed | Phase 2 | 56 | PfizerINDUSTRY | 1 | Nov 9, 2006 | clinicaltrials |
| NCT00050830 | A Phase 2, Randomized, Open-Label Study Of Single Agent CI-1033 In Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 163 | PfizerINDUSTRY | 8 | Nov 8, 2006 | clinicaltrials |
| NCT00132756 | Liposomal Doxorubicin and Estramustine Phosphate: Study in Taxane Resistant, Hormone Refractory Advanced Prostate Cancer | terminated | Phase 1 / Phase 2 | 30 | Morton Plant Mease Health CareOTHER | 1 | Nov 8, 2006 | clinicaltrials |
| NCT00174356 | PH 1 Evaluation Of Oral CI-1033 In Combination With Paclitaxel/ Carboplatin As 1st Line Chemotherapy In NSCLC Patients | completed | Phase 1 | 39 | PfizerINDUSTRY | 2 | Nov 8, 2006 | clinicaltrials |
| NCT00048464 | T Cell Immunotherapy for Multiple Myeloma Patients Undergoing a Bone Marrow Transplant | unknown | Phase 1 / Phase 2 | 35 | Xcyte TherapiesINDUSTRY | 1 | Nov 7, 2006 | clinicaltrials |
| NCT00074867 | Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 To Treat Small-Volume Ovarian, Peritoneal, Fallopian Tube Cancer | completed | Phase 2 | 29 | PfizerINDUSTRY | 2 | Nov 7, 2006 | clinicaltrials |
| NCT00104286 | Study of Troxatyl™ Administered by Continuous Infusion to Subjects With Solid Tumors | terminated | Phase 1 / Phase 2 | 50 | SGX Pharmaceuticals, Inc.INDUSTRY | 1 | Nov 3, 2006 | clinicaltrials |
| NCT00129948 | Study for Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) | terminated | Phase 2 | 211 | SGX Pharmaceuticals, Inc.INDUSTRY | 1 | Nov 3, 2006 | clinicaltrials |
| NCT00040170 | Vaccine Study of MVA-MUC1-IL2 in Patients With Prostate Cancer | terminated | Phase 2 | 50 | TransgeneINDUSTRY | 1 | Nov 2, 2006 | clinicaltrials |
| NCT00090727 | Chemotherapy for Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma | unknown | Phase 1 | 45 | NovaceaINDUSTRY | 1 | Nov 2, 2006 | clinicaltrials |
| NCT00080197 | Study to Evaluate the Efficacy, Safety, and Tolerability of E7070 in Metastatic Breast Cancer Patients | completed | Phase 2 | 250 | Eisai Inc.INDUSTRY | 2 | Oct 11, 2006 | clinicaltrials |
| NCT00385879 | The Effects of Case Management in a Medicaid Managed Care Plan | unknown | N/A | 500 | Metropolitan Jewish Health SystemOTHER | 1 | Oct 11, 2006 | clinicaltrials |
| NCT00333008 | A Dose Study of Doxil in a Dose Dense, 14 Day CDOP/Rituximab Regimen for Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma (NHL)> 60 Years or With Compromised Cardiac Status. | unknown | Phase 2 | 27 | The Alvin and Lois Lapidus Cancer InstituteOTHER | 1 | Sep 26, 2006 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials